ADMA Lawrence P Guiheen sells $158K worth of shares
May 24, 2025, 4:35 AM
0.00%
What does ADMA do
ADMA Biologics, headquartered in Ramsey, New Jersey, specializes in manufacturing FDA-approved plasma-derived biologics for immune deficiencies and infectious diseases, employing 624 staff. The company went public on October 17, 2013.
Lawrence P Guiheen sold 7,779 shares of ADMA on 21 May at $20.32 per share, worth a total of $158K. They now own 114,830 ADMA shares, or a 6% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.